Potassium Chloride

Product NDC: 64380-860
11-digit product format: 643800860
Labeler code: 64380
Product ID: 64380-860_a74390de-64e9-482d-8630-d1a2452324fe
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Potassium Chloride
Dosage form: TABLET, EXTENDED RELEASE
Route: ORAL
Labeler: Strides Pharma Science Limited
Application: ANDA210733
Marketing category: ANDA
Marketing start: 2018-11-19
Substance: POTASSIUM CHLORIDE
Active strength: 600 mg/1
Pharmacologic classes: Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 28 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	64380-860-08	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	64380-860-06	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	64380-860-07	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	64380-860-08	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	64380-860-06	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	64380-860-07	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	64380-860-08	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	64380-860-06	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	64380-860-07	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	64380-860-08	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	64380-860-06	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	64380-860-07	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	64380-860-07	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	64380-860-06	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	64380-860-08	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	64380-860-07	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	64380-860-06	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	64380-860-08	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	64380-860-07	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	64380-860-06	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	64380-860-08	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A210733-001	POTASSIUM CHLORIDE	POTASSIUM CHLORIDE	8MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2		2018-08-31
A210733-002	POTASSIUM CHLORIDE	POTASSIUM CHLORIDE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2		2018-08-31

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A210733-001	AB2
A210733-002	AB2

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A210733-001	POTASSIUM CHLORIDE	8MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-08-31	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A210733-002	POTASSIUM CHLORIDE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-08-31	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A210733-001	POTASSIUM CHLORIDE	8MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-08-31	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A210733-002	POTASSIUM CHLORIDE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-08-31	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A210733-001	POTASSIUM CHLORIDE	8MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-08-31	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A210733-002	POTASSIUM CHLORIDE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-08-31	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A210733-001	POTASSIUM CHLORIDE	8MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-08-31	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A210733-002	POTASSIUM CHLORIDE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-08-31	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A210733-001	POTASSIUM CHLORIDE	8MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-08-31	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A210733-002	POTASSIUM CHLORIDE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-08-31	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A210733-001	POTASSIUM CHLORIDE	8MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-08-31	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A210733-002	POTASSIUM CHLORIDE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-08-31	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A210733-001	POTASSIUM CHLORIDE	8MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-08-31	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A210733-002	POTASSIUM CHLORIDE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-08-31	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A210733-001	POTASSIUM CHLORIDE	8MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-08-31	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A210733-002	POTASSIUM CHLORIDE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-08-31	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A210733-001	POTASSIUM CHLORIDE	8MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-08-31	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A210733-002	POTASSIUM CHLORIDE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-08-31	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A210733-001	POTASSIUM CHLORIDE	8MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-08-31	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A210733-002	POTASSIUM CHLORIDE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-08-31	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A210733-001	POTASSIUM CHLORIDE	8MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-08-31	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A210733-002	POTASSIUM CHLORIDE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-08-31	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A210733-001	POTASSIUM CHLORIDE	8MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-08-31	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A210733-002	POTASSIUM CHLORIDE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-08-31	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A210733-001	POTASSIUM CHLORIDE	8MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-08-31	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A210733-002	POTASSIUM CHLORIDE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-08-31	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A210733-001	POTASSIUM CHLORIDE	8MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-08-31	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A210733-002	POTASSIUM CHLORIDE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-08-31	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A210733-001	POTASSIUM CHLORIDE	8MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-08-31	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A210733-002	POTASSIUM CHLORIDE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-08-31	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A210733-001	POTASSIUM CHLORIDE	8MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-08-31	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A210733-002	POTASSIUM CHLORIDE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-08-31	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A210733-001	POTASSIUM CHLORIDE	8MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-08-31	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A210733-002	POTASSIUM CHLORIDE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-08-31	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A210733-001	POTASSIUM CHLORIDE	8MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-08-31	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A210733-002	POTASSIUM CHLORIDE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-08-31	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A210733-001	POTASSIUM CHLORIDE	8MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-08-31	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A210733-002	POTASSIUM CHLORIDE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-08-31	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A210733-001	POTASSIUM CHLORIDE	8MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-08-31	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A210733-002	POTASSIUM CHLORIDE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-08-31	`bb7c543d1eb4…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	A210733-001	AB2	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A210733-002	AB2	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A210733-001	AB2	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A210733-002	AB2	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A210733-001	AB2	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A210733-002	AB2	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A210733-001	AB2	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A210733-002	AB2	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A210733-001	AB2	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A210733-002	AB2	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A210733-001	AB2	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A210733-002	AB2	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A210733-001	AB2	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A210733-002	AB2	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A210733-001	AB2	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A210733-002	AB2	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A210733-001	AB2	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A210733-002	AB2	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A210733-001	AB2	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A210733-002	AB2	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A210733-001	AB2	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A210733-002	AB2	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A210733-001	AB2	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A210733-002	AB2	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A210733-001	AB2	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A210733-002	AB2	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A210733-001	AB2	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A210733-002	AB2	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A210733-001	AB2	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A210733-002	AB2	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A210733-001	AB2	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A210733-002	AB2	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A210733-001	AB2	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A210733-002	AB2	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A210733-001	AB2	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A210733-002	AB2	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A210733-001	AB2	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A210733-002	AB2	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A210733-001	AB2	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A210733-002	AB2	1	`bb7c543d1eb4…`

Additional Listing Data#

Finished product: Yes
Brand name base: Potassium Chloride
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
POTASSIUM CHLORIDE	600 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
660YQ98I10	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
312529	Internal RxNorm lookup
628953	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
0224e5b3-3c49-4e6e-aa78-1abcc6969246	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
9e37788c-b1bf-42ae-aac9-b60601606144	Product name	8	20260122
95250459-30e4-45c1-b08a-993044f49109	Product name	2	20250805
d9771140-739b-484b-ae64-b79528ff1211	Product name	3	20250801
efd58dcf-540a-4531-8766-e713129ca6f2	Product name	1	20250307
1527ac37-808d-43be-a63e-74e1258dbe46	Product name	9	20250219
bed0530e-f939-4541-956b-6928a2f6404f	Product name	1	20241008
cefa60e2-a5b5-493e-9c54-24735b7dc509	Product name	6	20240814
362d7abb-94e6-4c60-9a58-266894157713	Product name	1	20231023
594e2c86-3079-4e6e-96c9-48f7a8afc78d	Product name	1	20230718
9fcb7a91-de07-4f00-aabf-e4d6fda403d5	Product name	8	20230322
6bd95106-a412-1dad-b9cc-4cb74bfb27ce	Product name	2	20230315
9badc7be-250a-44ab-aa36-926af3f02679	Product name	1	20210527
0ec3537a-6c9b-432a-896c-b9ea8723049a	Product name	9	20200701
444b3e50-f226-46ef-bfca-2e7035d140cd	Product name	1	20190611
816b97af-edc5-4060-aff1-b814bdbcad50	Product name	1	20190415
7cda52fc-125f-421c-8fea-bc1974370c49	Product name	2	20180703
7916de40-e296-41f0-b811-6d0df1a33e2c	Product name	9	20180627
cefa60e2-a5b5-493e-9c54-24735b7dc509	Product name	2	20171212
419aab54-5d5a-4146-9453-026d4a9991be	Product name	2	20170525
26acd337-b838-40ac-bcbc-05c3b81c8712	Product name	1	20170323
d5e51f11-ad28-caa4-4b49-4143974782ad	Product name	1	20150831
290f523a-f9db-9774-b5a9-e1f908ac1782	Product name	1	20150828
0ca1d589-929b-4b33-bc5b-1d84abdafa6a	Product name	1	20150324
fc363c46-397b-4476-ac0f-70e43e8e4592	Product name	1	20150324
89dac932-b90a-4410-9ab1-84c53e57de25	Product name	1	20150316
5668b646-cd56-c3c7-bdea-3f6b1a8840db	Product name	1	20140508
810ab97e-f109-f41c-7c83-6a652a9cbf43	Product name	1	20140508
87711080-88eb-65c5-b2dd-bf99e700a372	Product name	1	20140508
8dbefedf-0a0d-a224-5a3c-66dc9e11c2dd	Product name	1	20140508
c6b65c52-69c7-df49-550a-a50c137f6218	Product name	1	20140508
ec2149b3-5c6d-5344-f757-c86411073075	Product name	1	20140508
ed912195-5da0-0f2f-6f4b-3ef17710cbe3	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
64380-860-06	2025-03-28	These highlights do not include all the information needed to use Potassium Chloride Extended-release Tablets, USP safely and effectively. See full prescribing information for Potassium Chloride Extended-release Tablets, USP. Potassium Chloride Extended-release Tablets, USP for oral use. Initial U.S. Approval: 1948
64380-860-06	2025-03-28	These highlights do not include all the information needed to use Potassium Chloride Extended-release Tablets, USP safely and effectively. See full prescribing information for Potassium Chloride Extended-release Tablets, USP. Potassium Chloride Extended-release Tablets, USP for oral use. Initial U.S. Approval: 1948
64380-860-06	2025-03-28	These highlights do not include all the information needed to use Potassium Chloride Extended-release Tablets, USP safely and effectively. See full prescribing information for Potassium Chloride Extended-release Tablets, USP. Potassium Chloride Extended-release Tablets, USP for oral use. Initial U.S. Approval: 1948
64380-860-07	2025-03-28	These highlights do not include all the information needed to use Potassium Chloride Extended-release Tablets, USP safely and effectively. See full prescribing information for Potassium Chloride Extended-release Tablets, USP. Potassium Chloride Extended-release Tablets, USP for oral use. Initial U.S. Approval: 1948
64380-860-07	2025-03-28	These highlights do not include all the information needed to use Potassium Chloride Extended-release Tablets, USP safely and effectively. See full prescribing information for Potassium Chloride Extended-release Tablets, USP. Potassium Chloride Extended-release Tablets, USP for oral use. Initial U.S. Approval: 1948
64380-860-07	2025-03-28	These highlights do not include all the information needed to use Potassium Chloride Extended-release Tablets, USP safely and effectively. See full prescribing information for Potassium Chloride Extended-release Tablets, USP. Potassium Chloride Extended-release Tablets, USP for oral use. Initial U.S. Approval: 1948
64380-860-08	2025-03-28	These highlights do not include all the information needed to use Potassium Chloride Extended-release Tablets, USP safely and effectively. See full prescribing information for Potassium Chloride Extended-release Tablets, USP. Potassium Chloride Extended-release Tablets, USP for oral use. Initial U.S. Approval: 1948
64380-860-08	2025-03-28	These highlights do not include all the information needed to use Potassium Chloride Extended-release Tablets, USP safely and effectively. See full prescribing information for Potassium Chloride Extended-release Tablets, USP. Potassium Chloride Extended-release Tablets, USP for oral use. Initial U.S. Approval: 1948
64380-860-08	2025-03-28	These highlights do not include all the information needed to use Potassium Chloride Extended-release Tablets, USP safely and effectively. See full prescribing information for Potassium Chloride Extended-release Tablets, USP. Potassium Chloride Extended-release Tablets, USP for oral use. Initial U.S. Approval: 1948
64380-860-06	2025-01-30	These highlights do not include all the information needed to use Potassium Chloride Extended-release Tablets, USP safely and effectively. See full prescribing information for Potassium Chloride Extended-release Tablets, USP. Potassium Chloride Extended-release Tablets, USP for oral use. Initial U.S. Approval: 1948
64380-860-06	2025-01-30	These highlights do not include all the information needed to use Potassium Chloride Extended-release Tablets, USP safely and effectively. See full prescribing information for Potassium Chloride Extended-release Tablets, USP. Potassium Chloride Extended-release Tablets, USP for oral use. Initial U.S. Approval: 1948
64380-860-06	2025-01-30	These highlights do not include all the information needed to use Potassium Chloride Extended-release Tablets, USP safely and effectively. See full prescribing information for Potassium Chloride Extended-release Tablets, USP. Potassium Chloride Extended-release Tablets, USP for oral use. Initial U.S. Approval: 1948
64380-860-07	2025-01-30	These highlights do not include all the information needed to use Potassium Chloride Extended-release Tablets, USP safely and effectively. See full prescribing information for Potassium Chloride Extended-release Tablets, USP. Potassium Chloride Extended-release Tablets, USP for oral use. Initial U.S. Approval: 1948
64380-860-07	2025-01-30	These highlights do not include all the information needed to use Potassium Chloride Extended-release Tablets, USP safely and effectively. See full prescribing information for Potassium Chloride Extended-release Tablets, USP. Potassium Chloride Extended-release Tablets, USP for oral use. Initial U.S. Approval: 1948
64380-860-07	2025-01-30	These highlights do not include all the information needed to use Potassium Chloride Extended-release Tablets, USP safely and effectively. See full prescribing information for Potassium Chloride Extended-release Tablets, USP. Potassium Chloride Extended-release Tablets, USP for oral use. Initial U.S. Approval: 1948
64380-860-08	2025-01-30	These highlights do not include all the information needed to use Potassium Chloride Extended-release Tablets, USP safely and effectively. See full prescribing information for Potassium Chloride Extended-release Tablets, USP. Potassium Chloride Extended-release Tablets, USP for oral use. Initial U.S. Approval: 1948
64380-860-08	2025-01-30	These highlights do not include all the information needed to use Potassium Chloride Extended-release Tablets, USP safely and effectively. See full prescribing information for Potassium Chloride Extended-release Tablets, USP. Potassium Chloride Extended-release Tablets, USP for oral use. Initial U.S. Approval: 1948
64380-860-08	2025-01-30	These highlights do not include all the information needed to use Potassium Chloride Extended-release Tablets, USP safely and effectively. See full prescribing information for Potassium Chloride Extended-release Tablets, USP. Potassium Chloride Extended-release Tablets, USP for oral use. Initial U.S. Approval: 1948

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
64380-860-06	Potassium Chloride	100 in 1 BOTTLE	TABLET, EXTENDED RELEASE	100	7
64380-860-07	Potassium Chloride	500 in 1 BOTTLE	TABLET, EXTENDED RELEASE	500	7
64380-860-08	Potassium Chloride	1000 in 1 BOTTLE	TABLET, EXTENDED RELEASE	1000	7

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
64380-860-06	EA - Each	64380-860	dbd92ab5-7c2f-4f60-a99d-6a586dfbbf65	1	2018-12-13
64380-860-07	EA - Each	64380-860	94926a3c-1b88-4b63-b75b-c52a456dd31a	1	2018-12-13
64380-860-08	EA - Each	64380-860	10158d4f-c796-4c68-ac02-b6d908f42490	1	2018-12-13

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
64380-860	POTASSIUM CHLORIDE TABLET, EXTENDED RELEASE [STRIDES PHARMA SCIENCE LIMITED]	7	Current NDC, Legacy NDC, 3 package rows	20250330_0224e5b3-3c49-4e6e-aa78-1abcc6969246.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 4 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Potassium Chloride	POTASSIUM CHLORIDE	Northwind Health Company, LLC	db4dc4ab-e0d4-7dc7-e053-2995a90ac46e	2026-01-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210733 application number: ANDA210733
Potassium Chloride	POTASSIUM CHLORIDE	Strides Pharma Science Limited	0224e5b3-3c49-4e6e-aa78-1abcc6969246	2025-08-09	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210733 application number: ANDA210733 ndc (product): 64380-860
Potassium Chloride	POTASSIUM CHLORIDE	Bryant Ranch Prepack	ab147ac2-d7d5-46d1-a2de-d866219197c1	2025-04-28	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210733 application number: ANDA210733
POTASSIUM CHLORIDE	POTASSIUM CHLORIDE	Direct_Rx	946b9568-671d-172a-e053-2a95a90ac827	2025-01-22	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210733 application number: ANDA210733

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
660YQ98I10	POTASSIUM CHLORIDE	7447-40-7	POTASSIUM CHLORIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
628953	potassium chloride 10 MEQ (750 MG) Extended Release Oral Tablet	PSN	0224e5b3-3c49-4e6e-aa78-1abcc6969246	7
312529	potassium chloride 8 MEQ (600 MG) Extended Release Oral Tablet	PSN	0224e5b3-3c49-4e6e-aa78-1abcc6969246	7
628953	potassium chloride 10 MEQ Extended Release Oral Tablet	SCD	0224e5b3-3c49-4e6e-aa78-1abcc6969246	7
312529	potassium chloride 8 MEQ Extended Release Oral Tablet	SCD	0224e5b3-3c49-4e6e-aa78-1abcc6969246	7
628953	K+ Chloride 10 MEQ Extended Release Oral Tablet	SY	0224e5b3-3c49-4e6e-aa78-1abcc6969246	7
312529	K+ Chloride 8 MEQ Extended Release Oral Tablet	SY	0224e5b3-3c49-4e6e-aa78-1abcc6969246	7
628953	Pot Chloride 10 MEQ Extended Release Oral Tablet	SY	0224e5b3-3c49-4e6e-aa78-1abcc6969246	7
312529	Pot Chloride 8 MEQ Extended Release Oral Tablet	SY	0224e5b3-3c49-4e6e-aa78-1abcc6969246	7
312529	potassium chloride 600 MG Extended Release Oral Tablet	SY	0224e5b3-3c49-4e6e-aa78-1abcc6969246	7
628953	potassium chloride 750 MG (potassium 10 mEq) Extended Release Oral Tablet	SY	0224e5b3-3c49-4e6e-aa78-1abcc6969246	7
628953	potassium chloride 750 MG Extended Release Oral Tablet	SY	0224e5b3-3c49-4e6e-aa78-1abcc6969246	7

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
64380-860-06	64380086006	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (64380-860-06)	2018-11-19	0000-00-00	No	No	Current
64380-860-07	64380086007	500 TABLET, EXTENDED RELEASE in 1 BOTTLE (64380-860-07)	2018-11-27	0000-00-00	No	No	Current
64380-860-08	64380086008	1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (64380-860-08)	2018-11-27	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Potassium Chloride	Strides Pharma Science Limited \| Strides Pharma Global Pte. Ltd.	2025-09-17	HUMAN PRESCRIPTION DRUG LABEL	9
Potassium Chloride	RPK Pharmaceuticals, Inc.	2024-12-19	HUMAN PRESCRIPTION DRUG LABEL	2